This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This up-to-date commentary/perspective article sheds light on the revolutionary approaches designed to target the principal viral weapon “RNA” used by RNA viruses (e.g., the severe acute respiratory syndrome coronavirus 2 “SARS-CoV-2”) to infect humans and spread infections, the genomic RNA strands.
In this article Drug Target Review’s Izzy Wood spoke to Sam Hasson, Director of Target Biology at Rgenta Therapeutics, a biotech firm in Massachusetts, US, that aims to develop small molecule therapeutics to target RNA processing. The field is faced with a number of obstacles that require specifically assay technologies to surmount.
1 Targets were then further validated by combining testing the most promising drug candidates and knocking down specific targets using short interfering RNA (siRNA) and antisense oligonucleotides (ASOs). We can test their viability in the population, speeding up discovery and saving resources associated with laboratory target validation.
This article outlines the various stages of such a workflow, from hypothesis generation to data cleaning and interpretation, referencing the project workflow diagram (Figure 1). At the heart of any research is the scientific question.
This article compiles recent high-profile clinical readouts and related news with small molecules of general interest and structures where they are available. Unlike sapropterin, sepiapterin is more active in cells and is also brain-penetrant.
This second ELRIG meeting on Therapeutic Oligonucleotides brings together esteemed scientists from academia, industry, and other members of the drug discovery community to explore the discovery, validation, and targeting of oligonucleotide-based drug candidates, including antisense oligonucleotides (ASOs) and small interfering RNA (siRNA).
Our overall mission at Arrakis is to expand the set of “druggable” targets for small-molecule medicines to include RNA. Today, we are pleased to announce that our article describing one such platform: “ PEARL-seq, A Photoaffinity Platform for the Analysis of Small Molecule-RNA Interactions ” was published in ACS Chemical Biology.
Forging the toolkit for subcellular omics Cellular components known as organelles, consisting of RNA and protein, exert vital influences on human wellbeing and ailments by sustaining equilibrium, managing growth and ageing, and producing energy.
In this week’s article, researchers in Shanghai, China identified 6 children with KIF1A mutations and compared their symptoms to cases in the literature. Instead, this is what is called a splicing mutation; it occurs at the boundary between coding DNA that is read into RNA and protein, and noncoding DNA that is excluded.
Using RNA-seq and through in vitro and in vivo studies, we determined that brusatol suppresses hepatocellular carcinoma progression by inducing ATF3-mediated ferroptosis. RNA sequencing (RNA-seq) and bioinformatics analyses of HCC cells were utilized to elucidate the mechanism underlying the effects of BRU in HCC.
Berberine anticancer properties are demonstrated due to the interaction of berberine with micro-RNA. The summarized information presented in this review article may help and lead the researchers, scientists/industry persons to use berberine as a promising candidate against cancer.
Circular RNAs (circRNAs) are a unique kind of non-coding RNA and play an important regulatory role in OP. RNA immunoprecipitation (RIP) and RNA pull-down assays were performed to validate the binding relationship among circ_0005753, PTBP1, and TXNIP.
As soon as the initial RNA genome sequence of the pathogen that would be named SARS-CoV-2 was published, CDC and other organizations began developing diagnostic tests. After sequencing, artificial intelligence adds context to RNA and DNA sequences through comparisons to others. Work on vaccines ensued too.
To investigate these proteins, the authors used RNA interference to silence Nup153 and KIF1A. Read the Article Rare Roundup A broad genetic test saved one newborn’s life. Read the Article The post #ScienceSaturday: September 9, 2023 appeared first on KIF1A. What’s a pre-print? Check out this #ScienceSaturday post to learn more.
Sign up to receive new articles from Asimov Press. Remdesivir and other broad-spectrum antivirals work by jamming up RNA-dependent RNA polymerase (RdRp), an enzyme that nearly all RNA viruses use to replicate their genomes. Nor was remdesivir as effective as people hoped. Unsubscribe any time.
Note: For simplicity I will use the term KIF1A when referring to UNC-104 Post-translational modifications: When we talk about modifications to proteins, it’s usually in the context of mutations – a modification to the KIF1A gene makes altered RNA, which translates into altered KIF1A protein. What’s a pre-print?
However, it is not clear whether propofol mediates OSCC progression through regulating circular RNA (circRNA) network. RNA interaction was confirmed by dual-luciferase reporter assay and RIP assay. Abstract Propofol has been shown to inhibit oral squamous cell carcinoma (OSCC) progression.
Haemoglobin A1c (HbA1c) is a validated surrogate endpoint for the reduction of microvascular complications associated with diabetes mellitus; reduced HIV-RNA levels serve as an endpoint for HIV disease control; and a reduction in low-density lipoprotein (LDL) cholesterol is used as an endpoint indicating lower likelihood of cardiovascular events.
A gradient of emodin and long noncoding RNA HCP5 overexpression plasmid/small interfering RNA targeting HCP5 (siHCP5) were used for treating CRC cells. Expression levels of RNAs and proteins were detected by utilizing quantitative real-time polymerase chain reaction and Western blot.
The prognostic value of long noncoding RNA (lncRNA) LINC00460 has been reported in cervical cancer. The interaction between miR-338-3p and LINC00460 or transforming growth factor β-induced protein (TGFBI) was confirmed by RNA immunoprecipitation (RIP) and luciferase reporter assays.
cells induced by poly (I:C) were treated with or without PA, and then RNA-sequencing, GO and KEGG analysis were carried out to obtain the five differentially expressed genes (IL-1β, HMOX1, PTGS2, Abca1, and P65), which were verified by QRT-PCR and western blot. RNA-sequencing was applied to analyze the differentially expressed genes (DEGs).
In this week’s article, researchers in Brazil identified a KIF1A mutation in a cohort of patients with congenital ataxia. Later, she developed an interest in the RNA world, specifically focusing on alternative splicing and its correlation with neuron cell properties within and across cell types.
An oligonucleotide is a short strand of nucleotides, the building blocks of DNA or RNA, used in genetic research and therapy. Our experts stay up to date on all new and evolving regulations to guarantee regulatory compliance in your studies. Have questions about your oligonucleotide therapeutic studies? Get in touch with our experts today.
Meanwhile, circular RNA (circRNA) circ_0001615 has been reported to be involved in the malignant development of CRC. The binding between miR-873-5p and circ_0001615, or LASP1, was predicted by Starbase, followed by verification by dual-luciferase reporter and RNA immunoprecipitation (RIP) assays.
Genetic and RNA-based therapies seek to correct mutant KIF1A – improving its force generation, velocity, and distance traveled by increasing the ratio of healthy to mutant KIF1A. Read the Article The post #ScienceSaturday: July 29, 2023 appeared first on KIF1A.
More explanation and practical tips for using these technologies will be explored in future articles. 2 AlphaFold 3 has been built to model DNA, RNA and smaller molecules (ligands). These are foundational to drug discovery and will be discussed in future articles. Alphafold 3.0: the AI protein predictor gets an upgrade.
” The report accompanies an article in Science , also released today, entitled “Confronting Risks of Mirror Life.” For the article in Science , more than 30 scientists from ten countries are calling on the broader community to confront the risks of mirrored life. ” But what, exactly, is a mirrored organism?
RNA sequencing analysis was conducted to study the gene expression profiles of Formononetin-induced H1975_OR cells. However, the potentials and the mechanisms of Formononetin to counteract the Osimertinib resistance in NSCLC are unclear.
We then incubate the cells to mature into ‘pro-regenerative’ macrophages and insert two RNA messages to produce two human proteins that will be expressed at the site of injury when these ‘engineered’ macrophages are given back to the patient. The patient’s own monocytes, a type of white blood cell, are removed via an apheresis procedure.
Abstract N6-methyladenosine (m6A) modification and m6A-related RNA-binding proteins (RBPs) play vital roles in various aspects of circRNA metabolism. Hsa_circRNA_103820, downregulated by IGF2BP3, could encode a 188-aa peptide and inhibited lung cancer cell malignant progression by inhibiting the AKT pathway.
The differentially expressed genes (DEGs) were identified by RNA-seq and subjected to GO and KEGG pathway analyses. The mouse model of ammonia-induced lung fibrosis was established, and the role of PLD was assessed by H&E and Masson's trichrome staining. BEAS-2B cells were treated with NH 4 Cl alone or along with PLD.
CyclinD1, MMP2, RNA-binding motif protein 3 (RBM3), embryonic lethal abnormal visual-like protein 1 (ELAVL1), Wnt3A, and β-catenin protein levels were assessed using western blot. RBM3 and ELAVL1 expression was measured using real-time quantitative polymerase chain reaction (RT-qPCR).
To clarify how A6 affected on MCF-7 cells, RNA-seq analysis was conducted to evaluate the whole genome effect of A6 on gene expression. A6 significantly disrupted the amino acid metabolism and inhibited migration of MCF-7. In addition, A6 induced apoptosis of MCF-7 cells.
Circular RNA (circRNA) is an important regulator of gastric cancer progression. Sino suppressed GC cell proliferation, migration, invasion, and promoted apoptosis via regulating the circTRPM7/miR-145-5p/PBX3 axis. Abstract Sinomenine has been found to have antitumor effects in a variety of cancers, including gastric cancer.
The binding between miR-653-5p and circ_0139658 or Yin Yang 1 (YY1), was verified using dual-luciferase reporter and RNA pull-down assays. Cell proliferation, apoptosis, invasion, migration, as well as inflammatory response were evaluated by CCK-8 assay, EdU assay, flow cytometry, transwell assay, and ELISA analysis, respectively.
MiR-556-3p and Acyl-CoA synthetase long-chain family member 4 (ACSL4) interaction was confirmed via dual-luciferase reporter assay and RNA pull-down assay. The expression levels of microRNA (miR)-556-3p and ACSL4 were tested via quantitative real-time PCR.
circinteractome, and CircBank and validated using dual-luciferase reporter and RNA pull-down assays. The molecular mechanisms related to circ_0068464 were predicted through online prediction websites Starbase 2.0, The tumorigenic ability of BD and circ_0068464 on CRC was confirmed by xenograft experiments.
Published on bit.bio’s website, this article authored by Dr Tony Oosterveen dives into the close relationship between FTD and ALS with a focus on mechanisms underlying the neuropathology of both diseases. 14 TDP-43 is a DNA and RNA binding protein that regulates the expression and splicing of several target transcripts.
CRS rabbit models were constructed by Staphylococcus aureus infection and rabbits were injected with lentiviral vectors of short hairpin RNA-targeting Chemerin (shChemerin), followed by micro-computed tomography (CT) scan. Patients suffering from CRS without/with nasal polyps (CRSsNP/CRSwNP), along with volunteers, were recruited.
The m 6 A-RNA immunoprecipitation (MeRIP) assay detected the m 6 A modification profile. Oxidative stress was analyzed by detecting the contents of reactive oxygen species (ROS), superoxide dismutase (SOD) and malondialdehyde (MDA). The binding of miR-4654 and SOD2 was confirmed by dual-luciferase reporter assay.
When the expression of TGFBR3 on the surface of tumor cells (HeLa) was knocked down by RNA interference, the high delivery efficiency of T3BP was correspondingly reduced by 40%, indicating that the delivery was TGFBR3-dependent.
In this week’s article, researchers in Japan performed whole genome sequencing on 315 patients who were enrolled in the HAM patient registry. We each have two DNA copies of the KIF1A gene; each copy is called an allele and makes its own RNA, which is then translated into protein. What is an allele specific ASO?
Now Avidity Biosciences has developed a candidate drug that weds a monoclonal antibody (MAb) to a short piece of RNA – a small interfering RNA (siRNA). This novel class of RNA therapeutics is called Antibody Oligonucleotide Conjugates (AOCs™). Synthesizing a bit of RNA, Levin writes, is the simple part.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content